Images in cardiovascular medicine. Abciximab-associated pseudothrombocytopenia.
Holmes
M B
MB
University of Vermont College of Medicine, Burlington 05401, USA. michael.holmes@vtmednet.org
Kabbani
S
S
Watkins
M W
MW
Battle
R W
RW
Schneider
D J
DJ
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects; D016477:Artifacts; D005260:Female; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D010976:Platelet Count / Q000187:drug effects*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis*
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D000077284:Abciximab